These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 32634814)

  • 1. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adolescents with concurrent ADHD and substance use disorder; international consensus].
    Spijkerman R; Crunelle CL; Özgen MH; Begeman AHA; Dom G; van de Glind G; Groenman AP; van Kernebeek MW; Matthys F; Post M; Schellekens A; Staal W; van den Brink W; Hendriks VM
    Tijdschr Psychiatr; 2021; 63(12):868-874. PubMed ID: 34978058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
    Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Demetrovics Z; Coetzee C; Luderer M; Schellekens A; ; Matthys F
    Eur Addict Res; 2018; 24(1):43-51. PubMed ID: 29510390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [International consensus for the screening, diagnosis and treatment of adult patients with substance use disorder and ADHD].
    Crunelle CL; van den Brink W; Schellekens A; van de Glind G; Icasa Consortium B; Matthys F
    Tijdschr Psychiatr; 2019; 61(7):477-487. PubMed ID: 31372969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
    Schubiner H
    CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ADHD in adult patients with substance use disorders].
    Luderer M; Kiefer F; Reif A; Moggi F
    Nervenarzt; 2019 Sep; 90(9):926-931. PubMed ID: 31407043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
    Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.
    Tamm L; Trello-Rishel K; Riggs P; Nakonezny PA; Acosta M; Bailey G; Winhusen T
    J Subst Abuse Treat; 2013 Feb; 44(2):224-30. PubMed ID: 22889694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens A; Dalsgaard S; van den Brink W; Hendriks V
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder].
    Kapitány-Fövény M; Barta C; Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Coetzee C; Luderer M; Schellekens A; Matthys F; Demetrovics Z;
    Psychiatr Hung; 2020; 35(4):435-447. PubMed ID: 33263293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.
    Pérez de los Cobos J; Siñol N; Pérez V; Trujols J
    Br J Clin Pharmacol; 2014 Feb; 77(2):337-56. PubMed ID: 23216449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.
    Van de Glind G; Brynte C; Skutle A; Kaye S; Konstenius M; Levin F; Mathys F; Demetrovics Z; Moggi F; Ramos-Quiroga JA; Schellekens A; Crunelle C; Dom G; van den Brink W; Franck J
    Eur Addict Res; 2020; 26(4-5):173-178. PubMed ID: 32599579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations.
    Klassen LJ; Bilkey TS; Katzman MA; Chokka P
    Curr Drug Abuse Rev; 2012 Sep; 5(3):190-8. PubMed ID: 22571450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review.
    Zaso MJ; Park A; Antshel KM
    J Atten Disord; 2020 Jul; 24(9):1215-1226. PubMed ID: 25655767
    [No Abstract]   [Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder and early-onset substance use disorders.
    Wilson JJ; Levin FR
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):751-63. PubMed ID: 16262592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications.
    van der Burg D; Crunelle CL; Matthys F; van den Brink W
    Curr Opin Psychiatry; 2019 Jul; 32(4):300-306. PubMed ID: 31008730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.